Time-dependent biodistribution and excretion of silver nanoparticles in male Wistar rats

Journal of Applied Toxicology

Volumn 32, Issue 11, 2012, Pages 920-928

  Dziendzikowska, K ^a   Gromadzka Ostrowska, J ^a   Lankoff, A ^b,c   Oczkowski, M ^a   Krawczynska A ^a   Chwastowska, J ^c   Sadowska Bratek, M ^c   Chajduk, E ^c   Wojewodzka M ^c   Dusinska M ^d   Kruszewski, M ^c,e  

^a WARSAW UNIVERSITY OF LIFE SCIENCES   (Poland)

^b JAN KOCHANOWSKI UNIVERSITY   (Poland)

^c INSTITUTE OF NUCLEAR CHEMISTRY AND TECHNOLOGY   (Poland)

^d NORWEGIAN INSTITUTE FOR AIR RESEARCH   (Norway)

^e INSTITUTE OF AGRICULTURAL MEDICINE   (Poland)

Author keywords

Cellular uptake; Electron microscopy; Mass spectrometry; Nanoparticle accumulation; Tissue distribution

Indexed keywords

SILVER NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; BRAIN; CELL LEVEL; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG LIVER LEVEL; DYNAMIC LIGHT SCATTERING; FECES; KIDNEY; LIGHT SCATTERING; LUNG; MALE; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; RAT; SCANNING TRANSMISSION ELECTRON MICROSCOPY; SPLEEN; URINARY EXCRETION; ZETA POTENTIAL;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; FECES; LIVER; MALE; MASS SPECTROMETRY; METAL NANOPARTICLES; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, ELECTRON, TRANSMISSION; RATS; RATS, WISTAR; SILVER; TISSUE DISTRIBUTION;

RATTUS; RATTUS NORVEGICUS;

EID: 84866873854     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.2758     Document Type: Article

References (46)

1. Abdelhalim MA, Jarrar BM. 2011. The appearance of renal cells cytoplasmic degeneration and nuclear destruction might be an indication of GNPs toxicity. Lipids Health Dis. 10: 147.
2. Ananth AN, Daniel SC, Sironmani TA, Umapathi S. 2011. PVA and BSA stabilized silver nanoparticles based surface-enhanced plasmon resonance probes for protein detection. Colloids Surf. B Biointerfaces 85: 138-144.
3. Asare N, Instanes C, Sandberg WJ, Refsnes M, Schwarze P, Kruszewski M, Brunborg G. 2012. Cytotoxic and genotoxic effects of silver nanoparticles in testicular cells. Toxicology 291: 65-72.
4. Bouwmeester H, Poortman J, Peters RJ, Wijma E, Kramer E, Makama S, Puspitaninganindita K, Marvin HJ, Peijnenburg AA, Hendriksen PJ. 2011. Characterization of translocation of silver nanoparticles and effects on whole-genome gene expression using an in vitro intestinal epithelium coculture model. ACS Nano 5: 4091-4103.
5. Brunauer S, Emmett PH, Teller E. 1938. Adsorption of Gases in Multimolecular Layers. J. Am. Chem. Soc. 60: 309-319.
6. Carlson C, Hussain SM, Schrand AM, Braydich-Stolle LK, Hess KL, Jones RL, Schlager JJ. 2008. Unique cellular interaction of silver nanoparticles: size-dependent generation of reactive oxygen species. J. Phys. Chem. B 112: 13608-13619.
7. Choi HS, Liu W, Misra P, Tanaka E, Zimmer JP, Itty Ipe B, Bawendi MG, Frangioni JV. 2007. Renal clearance of quantum dots. Nat. Biotechnol. 25: 1165-1170.
8. Chrastina A, Schnitzer JE. 2010. Iodine-125 radiolabeling of silver nanoparticles for in vivo SPECT imaging. Int. J. Nanomedicine 5: 653-659.
9. De Jong WH, Burger MC, Verheijen MA, Geertsma RE. 2010. Detection of the Presence of Gold Nanoparticles in Organs by Transmission Electron Microscopy. Materials 3: 4681-4694.
10. Fabian E, Landsiedel R, Ma-Hock L, Wiench K, Wohlleben W, van Ravenzwaay B. 2008. Tissue distribution and toxicity of intravenously administered titanium dioxide nanoparticles in rats. Arch. Toxicol. 82: 151-157.
11. Garza-Ocañas L, Ferrer DA, Burt J, Diaz-Torres LA, Ramirez Cabrera M, Tamez Rodriguez V. 2010. Biodistribution and long-term fate of silver nanoparticles functionalized with bovine serum albumin in rats. Metallomics 2: 204-210.
12. Greulich C, Diendorf J, Simon T, Eggeler G, Epple M, Köller M. 2011. Uptake and intracellular distribution of silver nanoparticles in human mesenchymal stem cells. Acta Biomater. 7: 347-354.
13. Ji JH, Jung JH, Kim SS, Yoon JU, Park JD, Choi BS, Chung YH, Kwon IH, Jeong J, Han BS, Shin JH, Sung JH, Song KS, Yu IJ. 2007. Twenty-eight-day inhalation toxicity study of silver nanoparticles in Sprague-Dawley rats. Inhal. Toxicol. 19: 857-871.
14. Johnston HJ, Hutchison G, Christensen FM, Peters S, Hankin S, Stone V. 2010. A review of the in vivo and in vitro toxicity of silver and gold particulates: particle attributes and biological mechanisms responsible for the observed toxicity. Crit. Rev. Toxicol. 40: 328-346.
15. Kalishwaralal K, Barathmanikanth S, Pandian SR, Deepak V, Gurunathan S. 2010. Silver nano - a trove for retinal therapies. J. Control. Release 145: 76-90.
16. Kateb B, Chiu K, Black KL, Yamamoto V, Khalsa B, Ljubimova JY, Ding H, Patil R, Portilla-Arias JA, Modo M, Moore DF, Farahani K, Okun MS, Prakash N, Neman J, Ahdoot D, Grundfest W, Nikzad S, Heiss JD. 2011. Nanoplatforms for constructing new approaches to cancer treatment, imaging, and drug delivery: what should be the policy? Neuroimage 54: 106-124.
17. Kim WY, Kim J, Park JD, Ryu HY, Yu IJ. 2009. Histological study of gender differences in accumulation of silver nanoparticles in kidneys of Fischer 344 rats. J. Toxicol. Environ. Health A 72: 1279-1284.
18. Kim YS, Kim JS, Cho HS, Rha DS, Kim JM, Park JD, Choi BS, Lim R, Chang HK, Chung YH, Kwon IH, Jeong J, Han BS, Yu J. 2008. Twenty-eight-day oral toxicity, genotoxicity, and gender-related tissue distribution of silver nanoparticles in Sprague-Dawley rats. Inhal. Toxicol. 20: 575-583.
19. Kim YS, Song MY, Park JD, Song KS, Ryu HR, Chung YH, Chang HK, Lee JH, Oh KH, Kelman BJ, Hwang IK, Yu IJ. 2010. Subchronic oral toxicity of silver nanoparticles. Part. Fibre Toxicol. 7: 1-20.
20. Kiruba SCG, Tharmaraj V, Sironman TA, Pitchumani K. 2010. Toxicity and immunological activity of silver nanoparticles. Appl. Clay Sci. 48: 547-551.
21. Klippstein R, Fernandez-Montesinos R, Castillo PM, Zaderenko AP, Pozo D. 2010. Silver Nanoparticles Interactions with the Immune System: Implications for Health and Disease, Silver Nanoparticles, Perez DP (ed.). ISBN: 978-953-307-028-5, p. 309-324 InTech. Available from: http://www.intechopen.com/articles/show/title/silver-nanoparticles-interactions-with-the-immune-system-implications-for-health-and-disease.
22. Kruszewski M, Brzoska K, Brunborg G, Asare N, Dobrzyńska M, Dušinská M, Fjellsbø LM, Georgantzopoulou A, Gromadzka-Ostrowska J, Gutleb AC, Lankoff A, Magdolenová Z, Pran ER, Rinna A, Instanes C, Sandberg W, Schwarze P, Stepkowski T, Wojewódzka M, Refsnes M. 2011. Toxicity of silver nanomaterials in higher eukaryotes. In Advances in Molecular Toxicology, Vol. 5, Fishbein JC (ed.). Elsevier: Amsterdam; 179-218.
23. Lankoff A, Sandberg WJ, Wegierek-Ciuk A, Lisowska H, Rafsnes M, Sartowska B, Schwarze P, Meczynska-Wielgosz S, Wojewodzka M, Kruszewski M. 2012. The effect of agglomeration state of silver and titanium dioxide nanoparticles on cellular response in HepG2, A549 and THP-1 cells. Toxicol. Lett. 3: 197-213.
24. Lankveld DP, Oomen AG, Krystek P, Neigh A, Troost-de Jong A, Noorlander CW, Van Eijkeren JC, Geertsma RE, De Jong WH. 2010. The kinetics of the tissue distribution of silver nanoparticles of different sizes. Biomaterials 31: 8350-8361. DOI:10.1016/j.biomaterials.2010.07.045.
25. Li SD, Huang L. 2008. Pharmacokinetics and biodistribution of nanoparticles. Mol. Pharm. 5: 496-504.
26. Loeschner K, Hadrup N, Qvortrup K, Larsen A, Gao X, Vogel U, Mortensen A, Lam HR, Larsen EH. 2011. Distribution of silver in rats following 28days of repeated oral exposure to silver nanoparticles or silver acetate. Part. Fibre Toxicol. 8: 18.
27. Lynch I, Dawson KA. 2008. Protein-nanoparticle interactions. Nano Today 3: 40-47.
28. Martínez-Gutierrez F, Thi EP, Silverman JM, de Oliveira CC, Svensson SL, Hoek AV, Sánchez EM, Reiner NE, Gaynor EC, Pryzdial EL, Conway EM, Orrantia E, Ruiz F, Av-Gay Y, Bach H. 2012. Antibacterial activity, inflammatory response, coagulation and cytotoxicity effects of silver nanoparticles. Nanomedicine 8: 328-336.
29. Nagashima K, Zheng J, Parmiter D, Patri AK. 2011. Biological tissue and cell culture specimen preparation for TEM nanoparticle characterization. Methods Mol. Biol. 697: 83-91.
30. Nowack B, Krug HF, Height M. 2011. 120 Years of nanosilver history: implications for policy makers. Environ. Sci. Technol. 45: 1177-1183.
31. Park K, Park EJ, Chun IK, Choi K, Lee SH, Yoon J, Lee BC. 2011. Bioavailability and Toxicokinetics of Citrate-coated Silver Nanoparticles in Rats. Arch. Pharm. Res. 34: 153-158.
32. Patri A, Umbreit T, Zheng J, Nagashima K, Goering P, Francke-Carroll S, Gordon E, Weaver J, Miller T, Sadrieh N, McNeil S, Stratmeyer M. 2009. Energy dispersive X-ray analysis of titanium dioxide nanoparticle distribution after intravenous and subcutaneous injection in mice. J. Appl. Toxicol. 29: 662-672.
33. Sadauskas E, Wallin H, Stoltenberg M, Vogel U, Doering P, Larsen A, Danscher G. 2007. Kupffer cells are central in the removal of nanoparticles from the organism. Part. Fibre Toxicol. 4: 3-10.
34. Samuel U, Guggenbichler JP. 2004. Prevention of catheter-related infections: the potential of a new nano-silver impregnated catheter. Int. J. Antimicrob. Agents 23S1: 75-78.
35. Shapero K, Fenaroli F, Lynch I, Cottell DC, Salvati A, Dawson KA. 2011. Time and space resolved uptake study of silica nanoparticles by human cells. Mol. Biosyst. 7: 371-378.
36. Sonavane G, Tomoda K, Makino K. 2008. Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size. Colloids Surf. B Biointerfaces 66: 274-280.
37. Sung JH, Ji JH, Park JD, Yoon JU, Kim DS, Jeon KS, Song MY, Jeong J, Han BS, Han JH, Chung YH, Chang HK, Lee JH, Cho MH, Kelman BJ. 2009. Subchronic inhalation toxicity of silver nanoparticles. Toxicol. Sci. 108: 452-461.
38. Sung JH, Ji JH, Yoon JU, Kim DS, Song MY, Jeong J, Han BS, Han JH, Chung YH, Kim J, Kim TS, Chang HK, Lee EJ, Lee JH, Yu IJ. 2008. Lung function changes in Sprague-Dawley rats after prolonged inhalation exposure to silver nanoparticles. Inhal. Toxicol. 6: 567-574.
39. Szebeni J. 2011. Nanomedicine: application of nanotechnology in medicine. Opportunities in neuropsychiatry. Neuropsychopharmacol. Hung. 1: 15-24.
40. Takenaka S, Karg E, Roth C, Schulz H, Ziesenis A, Heinzmann U, Schramel P, Heyder J. 2001. Pulmonary and systemic distribution of inhaled ultrafine silver particles in rats. Environ. Health Perspect. 109(Suppl 4): 547-551.
41. Tang J, Xiong L, Wang S, Wang J, Liu L, Li J, Wan Z, Xi T. 2008. Influence of silver nanoparticles on neurons and blood-brain barrier via subcutaneous injection in rats. Appl. Surf. Sci. 255: 502-504.
42. Teixidó M, Giralt E. 2008. The role of peptides in blood-brain barrier nanotechnology. J. Pept. Sci. 14: 163-173.
43. Vaidyanathan R, Kalishwaralal K, Gopalram S, Gurunathan S. 2009. Nanosilver -- the burgeoning therapeutic molecule and its green synthesis. Biotechnol. Adv. 27: 924-937.
44. Vidler DS, Richard O, Jenkins RO, Hall JF, Harrington CF. 2007. The determination of methylmercury in biological samples by HPLC coupled to ICP-MS detection. Appl. Organomet. Chem. 21: 303-310.
45. Wojewódzka M, Lankoff A, Dusińska M, Brunborg G, Czerwińska A, Iwaneńko T, Stepkowski T, Szumiel I, Kruszewski M. 2011. Treatment with silver nanoparticles delays repair of X-ray induced DNA damage in HepG2 cells. Nukleonika 56: 29-33.
46. Wijnhoven SWP, Peijnenburg WJGM, Herberts CA, Hagens WI, Oomen AG, Heugens EHW, Roszek B, Bisschops J, Gosens I, Van De Meent D, Dekkers S, De Jong WH, van Zijverden M, Sips AJAM, Geertsma RE. 2009. Nano-silver a review of available data and knowledge gaps in human. Nanotoxicology 3: 109-138.